Investors of Reckitt Benckiser Group PLC urged to Lead Class Action Lawsuit for Securities Fraud

Opportunity for Reckitt Benckiser Investors

The Rosen Law Firm, a prominent global law firm specializing in investor rights, has brought attention to an important deadline for individuals who purchased American Depositary Shares (ADSs) of Reckitt Benckiser Group PLC (OTC: RBGLY). This notice serves as a reminder that the deadline to appoint a lead plaintiff for the ongoing securities fraud lawsuit is fast approaching, specifically on August 4, 2025.

Investors who acquired these shares between January 13, 2021, and July 28, 2024, might qualify for compensation, and doing so involves no out-of-pocket fees through a contingency fee arrangement. If you're eligible, you can take the initial step toward participating in the class action lawsuit against Reckitt Benckiser.

Next Steps for Interested Investors

To partake in this class action, stakeholders can follow a straightforward process: navigate to the Rosen Law Firm's website and fill out the submission form at Rosen Legal. For further inquiries, Phillip Kim, Esq., one of the firm's representatives, can be reached toll-free at 866-767-3653 or through email at [email protected].

It's important to note that a class action lawsuit has already been initiated. Should investors wish to serve as lead plaintiffs, they must file with the court by the August 4, 2025 deadline. Serving as a lead plaintiff means acting as a representative on behalf of other class members throughout the duration of the litigation.

Importance of Choosing Competent Legal Counsel

Rosen Law Firm emphasizes the significance of selecting qualified legal counsel with proven expertise in leading such cases. Many firms that issue notices lack comparable experience or resources, often acting as intermediaries that only refer clients to firms capable of actual litigation. Investors are encouraged to be discerning when choosing their legal representation.

The Rosen Law Firm is dedicated to representing investors worldwide, focusing extensively on securities class actions and shareholder derivative litigation. The firm notably achieved the largest settlement against a Chinese company at that time and has been consistently ranked highly for its performance in securing favorable settlements. In 2019 alone, they recovered over $438 million for their clients. Furthermore, Laurence Rosen, the founding partner of the firm, was recognized as one of the top figures in the Plaintiffs' Bar by Law360.

Details of the Allegations

The lawsuit claims that during the designated Class Period, Reckitt Benckiser Group PLC and its executives allegedly failed to disclose crucial information regarding the safety of their Enfamil cow's milk-based formula. Specifically, the company was accused of not warning investors about the heightened risk that preterm infants faced when using this product, leading to a potential increase in claims against Reckitt. The positive statements made by the company about its performance, operations, and growth prospects were deemed materially misleading or entirely unsubstantiated. As this critical information emerged in the public domain, investors in Reckitt Benckiser allegedly suffered significant damages.

Conclusion

For those who invested in Reckitt Benckiser Group PLC ADSs during the specified period, this class action represents an opportunity for potential compensation. However, first steps need to be taken promptly as the deadline for appointing a lead plaintiff is imminent. Please visit the Rosen Law Firm’s website to learn more and to ensure that your rights as an investor are protected.

For ongoing updates regarding the case and the firm, you can follow Rosen Law Firm’s professional pages on social media platforms like LinkedIn, Twitter, and Facebook.